In this podcast, Gregg W. Stone, MD, talks about the take-home messages from the EXCEL Clinical Trial, which evaluated the effectiveness of drug-eluting stents vs coronary artery bypass grafting for left main revascularization. He also presented the results at the recent 2021 VEITHsymposium. More at: www.consultant360.com